ARWR β€” ARROWHEAD PHARMACEUTICALS IN

Ownership history in Western Financial Corp/CA  Β·  13 quarters on record

AI Ownership Summary

Western Financial Corp/CA reported ARROWHEAD PHARMACEUTICALS IN (ARWR) in 13 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 21.6% in 2025 Q4. The latest visible filing shows ARWR at 21.60% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this ARWR ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Western Financial Corp/CA's position in ARROWHEAD PHARMACEUTICALS IN, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

ARWR was reported at 21.60% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
21.6% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Western Financial Corp/CA held ARWR β€” position size vs. price
% of Fund (quarterly)    ARWR price (quarter-end, indexed to 100)
πŸ“‹ Quarterly Holdings History 9 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 UNCHANGED 820,239 β€” 0% 21.60% $54.5M 2026-02-14 (Est.) $63.82
2025 Q3 UNCHANGED 820,239 β€” 0% 12.31% $28.3M 2025-10-21 $38.03
2025 Q2 UNCHANGED 820,239 β€” 0% 6.95% $13.0M 2025-07-17 $18.85
2025 Q1 UNCHANGED 820,239 β€” 0% 6.07% $10.4M 2025-04-23 $13.01
2024 Q4 UNCHANGED 820,239 β€” 0% 8.47% $15.4M 2025-01-24 $20.76
2024 Q3 UNCHANGED 820,239 β€” 0% 9.02% $15.9M 2024-10-21 $20.49
2024 Q2 UNCHANGED 820,239 β€” 0% 12.88% $21.3M 2024-07-19 $28.30
2024 Q1 UNCHANGED 820,239 β€” 0% 14.38% $23.5M 2024-04-24 $23.29
2023 Q4 UNCHANGED 820,239 β€” 0% 16.79% $25.1M 2024-01-25 $33.42
4 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

FAQ About Western Financial Corp/CA and ARWR

These are the practical questions this page is built to answer before you even open the full history table.

How long has Western Financial Corp/CA reported owning ARWR?

Western Financial Corp/CA reported ARWR across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported ARWR position in Western Financial Corp/CA's portfolio?

The largest reported portfolio weight for ARWR was 21.60% in 2025 Q4.

What is the latest reported ARWR position on this page?

The most recent filing on this page is 2025 Q4, when Western Financial Corp/CA reported 820,239 shares, equal to 21.60% of portfolio, with an estimated market value of $54.5M.

What does the chart on this ARWR ownership page compare?

The chart compares Western Financial Corp/CA's quarterly ARWR portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Western Financial Corp/CA Holdings